Bulimia Nervosa: A Biobehavioral Study (The Eating Disorder Study)
NCT ID: NCT01830374
Last Updated: 2018-07-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
132 participants
OBSERVATIONAL
2012-08-31
2018-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Motivating Factors That Play a Role in Bulimia Nervosa
NCT00304174
Self-regulatory Control and Eating: A Neuroimaging Study of Bulimia Nervosa
NCT01935401
An fMRI Study of Self-regulation in Adolescents With Bulimia Nervosa
NCT00345943
Changes in Inhibition and Valuation After Eating
NCT05995496
Neurofeedback During Eating for Bulimia Nervosa
NCT05614024
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Women with bulimia nervosa
This is not a treatment study. All participants will go through the same steps.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Either currently receiving eating disorder treatment or actively seeking treatment
* BMI above 18.5 and below 30
* Not experiencing any signs of menopause
* Medically stable as determined by each site's study physician
Exclusion Criteria
* Currently taking atypical antipsychotic medications
* History of anorexia nervosa within the past year
* Pregnancy
* Currently taking medications that could alter hormone levels or metabolism
* Disorders affecting metabolism or hormone levels
* Non-removal metallic object
* Co-occurring severe mental illness
* At risk for suicide
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Columbia University
OTHER
The Miriam Hospital
OTHER
Drexel University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael Lowe
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael R. Lowe, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Drexel University
Laurel Mayer, M.D.
Role: PRINCIPAL_INVESTIGATOR
Columbia University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Columbia University
New York, New York, United States
Drexel University
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12090001548
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.